Chan D - Search Results

1

Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells.

Modiano JF, Sun J, Lang J, Vacano G, Patterson D, Chan D, Franzusoff A, Gianani R, Meech SJ, Duke R, Bellgrau D. Modiano JF, et al. Among authors: chan d. Clin Immunol. 2004 Jul;112(1):54-65. doi: 10.1016/j.clim.2004.03.011. Clin Immunol. 2004. PMID: 15207782

2

Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance.

Singh RP, Mallikarjuna GU, Sharma G, Dhanalakshmi S, Tyagi AK, Chan DC, Agarwal C, Agarwal R. Singh RP, et al. Clin Cancer Res. 2004 Dec 15;10(24):8641-7. doi: 10.1158/1078-0432.CCR-04-1435. Clin Cancer Res. 2004. PMID: 15623648

3

Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC).

Bren-Mattison Y, Van Putten V, Chan D, Winn R, Geraci MW, Nemenoff RA. Bren-Mattison Y, et al. Among authors: chan d. Oncogene. 2005 Feb 17;24(8):1412-22. doi: 10.1038/sj.onc.1208333. Oncogene. 2005. PMID: 15608671

4

RING-dependent tumor suppression and G2/M arrest induced by the TRC8 hereditary kidney cancer gene.

Brauweiler A, Lorick KL, Lee JP, Tsai YC, Chan D, Weissman AM, Drabkin HA, Gemmill RM. Brauweiler A, et al. Among authors: chan d. Oncogene. 2007 Apr 5;26(16):2263-71. doi: 10.1038/sj.onc.1210017. Epub 2006 Oct 2. Oncogene. 2007. PMID: 17016439

5

Synergistic anti-cancer effects of grape seed extract and conventional cytotoxic agent doxorubicin against human breast carcinoma cells.

Sharma G, Tyagi AK, Singh RP, Chan DC, Agarwal R. Sharma G, et al. Breast Cancer Res Treat. 2004 May;85(1):1-12. doi: 10.1023/B:BREA.0000020991.55659.59. Breast Cancer Res Treat. 2004. PMID: 15039593

6

Induction of E-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition.

Kakihana M, Ohira T, Chan D, Webster RB, Kato H, Drabkin HA, Gemmill RM. Kakihana M, et al. Among authors: chan d. J Thorac Oncol. 2009 Dec;4(12):1455-65. doi: 10.1097/JTO.0b013e3181bc9419. J Thorac Oncol. 2009. PMID: 20009910 Free PMC article.

7

Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines.

Hirsch FR, Helfrich B, Franklin WA, Varella-Garcia M, Chan DC, Bunn PA Jr. Hirsch FR, et al. Clin Breast Cancer. 2002 May;3 Suppl 1:12-6. doi: 10.3816/cbc.2002.s.003. Clin Breast Cancer. 2002. PMID: 12057039 Review.

8

Preclinical efficacy of a carboxylesterase 2-activated prodrug of doxazolidine.

Barthel BL, Zhang Z, Rudnicki DL, Coldren CD, Polinkovsky M, Sun H, Koch GG, Chan DC, Koch TH. Barthel BL, et al. Among authors: chan dc. J Med Chem. 2009 Dec 10;52(23):7678-88. doi: 10.1021/jm900694z. J Med Chem. 2009. PMID: 19634903 Free PMC article.

9

Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells.

Argast GM, Croy CH, Couts KL, Zhang Z, Litman E, Chan DC, Ahn NG. Argast GM, et al. Among authors: chan dc. Oncogene. 2009 Jul 30;28(30):2697-709. doi: 10.1038/onc.2009.133. Epub 2009 Jun 1. Oncogene. 2009. PMID: 19483722 Free PMC article.

10

Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth.

Wick M, Hurteau G, Dessev C, Chan D, Geraci MW, Winn RA, Heasley LE, Nemenoff RA. Wick M, et al. Among authors: chan d. Mol Pharmacol. 2002 Nov;62(5):1207-14. doi: 10.1124/mol.62.5.1207. Mol Pharmacol. 2002. PMID: 12391285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,848 results

Search Page

Filters